Hans Jörg Reinhardt

Former Chief Operating Officer at Novartis Corporation

Hans Jörg Reinhardt

Hans Jörg Reinhardt

Former Chief Operating Officer at Novartis Corporation

Overview

Career Highlights

Novartis Corporation
Novartis AG
Bayer HealthCare AG

RelSci Relationships

1664

Number of Boards

14

Birthday

1956

Age

64

Number of Awards

1

Contact Data

Trying to get in touch with Hans Jörg Reinhardt? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals Hans Jörg Reinhardt likely has professional access to. A relationship does not necessarily indicate a personal connection.

Andrin Oswald

Head of the Novartis Vaccines & Diagnostics Division at Novartis Corporation

Relationship likelihood: Strong

Harry Werner Kirsch

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Vasant Narasimhan

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Rolf Zinkernagel

Founder at Hookipa Pharma, Inc.

Relationship likelihood: Strong

Andreas Von Planta

Partner at Lenz & Staehelin AG

Relationship likelihood: Strong

Ulrich Lehner

Independent Deputy Chairman of the Supervisory Board at E.ON SE

Relationship likelihood: Strong

Daniel Vasella

Chairman at Alcon Laboratories, Inc.

Relationship likelihood: Strong

Pierre Landolt

Chairman at Sandoz Family Foundation

Relationship likelihood: Strong

Werner Baumann

Chief Executive Officer at Bayer AG

Relationship likelihood: Strong

Ann Marie Fudge

Former Chairman & Chief Executive Officer at Young & Rubicam Brands, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

Nasdaq

September 1, 2020

Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality

Thomson Reuters ONE

September 1, 2020

Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality

Reinsurance News

March 20, 2020

Swiss Re Board nominates three new members for election

ENP Newswire

March 20, 2020

-Swiss Re to propose increase in regular dividend to CHF 5.90 per share

Thomson Reuters ONE

February 28, 2020

Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting

Paths to Hans Jörg Reinhardt

Potential Connections via
Relationship Science

You

Hans Jörg Reinhardt

Former Chief Operating Officer at Novartis Corporation

Education

Doctorate, Pharmaceutical Sciences

Universität Saarbrücken

Saarland University is a modern university within the Saar-Lor-Lux region – a dynamic part of Europe defined by the shared borders between Germany, France and Luxembourg. An international perspective has been a defining feature of Saarland University ever since it was established in cooperation with France in 1948. Today, 18.500 young people are studying in Saarbrücken and Homburg (faculty of medicine), 17 per cent of whom are international students. Located in a pleasant woodland setting, the university campus offers students and researchers a broad range of sporting and cultural activities, which together with the numerous cafés and restaurants make the campus an ideal place to relax between lectures or after work. And thanks to the high-speed ICE train link it takes only two hours to travel from Saarbrücken to Paris.

Career History

Chief Operating Officer

Tenure Unconfirmed

Novartis Corporation

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Chief Executive Officer

2010 - 2013

Bayer HealthCare AG

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.

Chief Operating Officer

2006 - 2010

Novartis AG

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees

Chairman

Current

Novartis Institutes for BioMedical Research, Inc.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Director

2012 - 2013

Lonza Group AG

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Chairman

Prior

Novartis Institute For Functional Genomics, Inc.

Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA.

Chairman, Board of Trustees

Current

Novartis Foundation

Council Member

2010 - ?

International Federation of Pharmaceutical Manufacturers

Founded in 1968, the IFPMA is a global, non-profit, nongovernmental organization. With members across the globe and a secretariat based in Geneva, Switzerland, the IFPMA represents the research-based pharmaceutical industry, including the biotechnology and vaccine sectors.

Public Holdings

Restricted data only for RelSci Professional users.

Awards & Honors

2013

Malaria No More International - Global Leadership Award

Other Affiliations

Hans Jörg Reinhardt is affiliated with Novartis Corporation, Bayer HealthCare AG, Novartis AG, Sandoz Pharmaceuticals AG, Sandoz Pharma Ltd., Novartis Vaccines & Diagnostics, Inc., Novartis Institutes for BioMedical Research, Inc., Lonza Group AG, Novartis Institute For Functional Genomics, Inc., Bayer HealthCare AG, Novartis Foundation, International Federation of Pharmaceutical Manufacturers

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hans Jörg Reinhardt. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hans Jörg Reinhardt's profile does not indicate a business or promotional relationship of any kind between RelSci and Hans Jörg Reinhardt.